$NASDAQ:EXAS

Exact Sciences Stock Fair Value Calculation – Exact Sciences Schedules Q2 2023 Earnings Call to Report on Cancer Screening and Diagnostics Progress

🌧️Trending News EXACT SCIENCES ($NASDAQ:EXAS) Corporation is a global leader in cancer screening and diagnostics. The company is dedicated to [...]

Exact Sciences Intrinsic Value – Exact Sciences Surpasses Expectations with Record Revenue and Positive EPS

Trending News ☀️ Exact Sciences ($NASDAQ:EXAS) is a leading healthcare company that has just announced record revenue and a positive [...]

By |May 10, 2023|Categories: Diagnostics & Research|Tags: , , |0 Comments

Exact Sciences Reports Positive Developments, But Remains Unprofitable and Mediocre Guidance for 2023.

Trending News ☀️ Overall, Exact Sciences ($NASDAQ:EXAS) reported some positive developments in their Q4 results, but the company is still [...]

By |March 6, 2023|Categories: Diagnostics & Research|Tags: , , |0 Comments

EXACT SCIENCES Reports 42.1% Revenue Increase and 16.7% Increase in Net Income for FY2022 Q4

Earnings report On December 31 2022, EXACT SCIENCES ($NASDAQ:EXAS) reported their earnings results for FY2022 Q4 ending February 21 2023. [...]

Exact Sciences Corporation Reaps Rewards of Windfall in 2023, Stock Up Over a Third Since Start of Year

Trending News ☀️ Exact Sciences ($NASDAQ:EXAS) Corporation, a cancer screening and diagnostic firm, saw a major jump in their stocks [...]

By |February 20, 2023|Categories: Diagnostics & Research|Tags: , , |0 Comments

Exact Sciences Intrinsic Value – Exact Sciences Corporation Shares Show Potential for Correction Following 2.13% Increase to $68.57.

Trending News ☀️ Exact Sciences Intrinsic Value - Exact Sciences ($NASDAQ:EXAS) Corporation is a publicly traded biotechnology company that specializes [...]

By |February 13, 2023|Categories: Diagnostics & Research, Intrinsic Value|Tags: , , |0 Comments
Go to Top